Representative Mike Kelly made $162.8K in the stock market last month, per Quiver Quantitative's live net worth estimates.
Representative Mike Kelly Net Worth
Quiver Quantitative estimates that Representative Mike Kelly is worth $16.1M, as of November 2nd, 2025. This is the 82nd highest net worth in Congress, per our live estimates.
Kelly has approximately $5.8M invested in publicly traded assets which Quiver is able to track live.
You can track Representative Mike Kelly's net worth on Quiver Quantitative's politician page for Kelly.
Representative Mike Kelly Stock Trading
We have data on up to $5.6M of trades from Representative Mike Kelly, which we parsed from STOCK Act filings. Some of the largest trades include:
- A March 28th, 2024 purchase of up to $100K of $CLF. The stock has fallen 45.34% since then.
- A June 20th, 2025 sale of up to $50K of $X.
- A November 8th, 2024 sale of up to $50K of $UNP. The stock has fallen 8.75% since then.
- A April 12th, 2024 sale of up to $15K of $VZ. The stock has risen 0.05% since then.
- A April 12th, 2024 sale of up to $15K of $CVX. The stock has fallen 0.78% since then.
You can track Representative Mike Kelly's stock trading on Quiver Quantitative's politician page for Kelly.
Representative Mike Kelly Bill Proposals
Here are some bills which have recently been proposed by Representative Mike Kelly:
- H.R.5275: Diagnostic Accuracy in Sepsis Act of 2025
- H.R.4566: Washington’s Trail—1753 National Historic Trail Feasibility Study Act of 2025
- H.R.4547: To advance Thomas B. Hagen on the retired list of the Navy.
- H.R.4231: Treat and Reduce Obesity Act of 2025
- H.R.4184: To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes.
- H.R.3687: To amend the Internal Revenue Code of 1986 to renew and enhance opportunity zones, and for other purposes.
You can track bills proposed by Representative Mike Kelly on Quiver Quantitative's politician page for Kelly.
Note that our net worth numbers are estimates, based on financial disclosures, and the data may be inaccurate or incomplete. See Quiver Quantitative's disclaimers for more information.
